CT测量脾脏体积对代偿期慢性乙型肝炎相关慢性肝病患者的预后作用
回顾性分析584例代偿期慢性乙型肝炎相关慢性肝病患者的肝脏多期CT,半自动三维体积软件测量脾脏体积。中位随访92个月,脾脏体积较大与肝细胞癌发生(HR=2.13,p=0.009)、肝功能失代偿(HR=4.66,p=0.005)及总生存较差(HR=6.15,p=0.007)显著相关。
要点
- 脾脏体积可从常规肝脏多期CT用半自动三维体积软件测量,观察者间一致性极好。
- 脾脏体积较大与肝细胞癌发生、肝功能失代偿及总生存较差显著相关。
- 预测肝细胞癌、失代偿及总生存的最佳脾脏体积截断值分别为532 mL、656.9 mL、741.1 mL。
诊断标准与关键数值
- 预测肝细胞癌发生的最佳脾脏体积截断值为532 mL。
- 预测肝功能失代偿的最佳脾脏体积截断值为656.9 mL。
- 预测总生存的最佳脾脏体积截断值为741.1 mL。
- 脾脏体积较大预测肝细胞癌发生的HR=2.13(p=0.009)。
- 脾脏体积较大预测肝功能失代偿的HR=4.66(p=0.005)。
临床应用与阅片要点
- 脾脏体积可从常规肝脏多期CT用半自动三维体积软件测量,观察者间一致性极好。
- 脾脏体积较大与肝细胞癌发生、肝功能失代偿及总生存较差显著相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the prognostic value of CT-based splenic volume measurement in patients with compensated chronic liver disease (cCLD) from chronic hepatitis B (CHB).
METHODS: A total of 584 patients having multiphasic liver CT scans between January and December 2011 were retrospectively reviewed. Spleen volume was measured using a semi-automated three-dimensional volumetric software program. Electronic medical records and national registry data were reviewed to determine the diagnosis of hepatocellular carcinoma (HCC), hepatic decompensation, or death. The cumulative incidence (CI) of the development of decompensation, HCC occurrence, and overall survival (OS) were estimated by the Kaplan-Meier method. The Cox proportional hazard regression model was used to evaluate prognostic factors. The optimal cutoff spleen volume to predict each outcome was obtained using a minimal p value approach method.
RESULTS: After a median follow-up of 92 months, 114 patients developed HCC with a 7-year CI of 17.2%. A larger spleen volume was a significant predictor of HCC occurrence (HR = 2.13, p = 0.009). Decompensation occurred in 30 patients with a 7-year CI of 5.0%, and a larger spleen volume was also significantly associated with the development of decompensation (HR = 4.66, p = 0.005). Twenty-three patients died, and their estimated 7-year OS was 96.4%. A larger spleen volume also significantly affected OS (HR = 6.15, p = 0.007). The optimal cutoff spleen volume was set at 532 mL for HCC occurrence, 656.9 mL for the development of decompensation, and 741.1 mL for OS.
CONCLUSIONS: A larger spleen volume was significantly associated with HCC occurrence, development of decompensation, and poor OS in patients with cCLD from CHB.
KEY POINTS: • Spleen volume could be easily acquired from routine multiphasic liver CT scan using a semi-automated 3D volumetric software program with excellent inter-observer agreement. • A larger spleen volume was significantly associated with a higher rate of hepatocellular carcinoma occurrence, the development of decompensation, and poor overall survival in patients with compensated chronic liver disease from chronic hepatitis B.
引用
- Yoo J, Kim SW, Lee DH, et al. Prognostic role of spleen volume measurement using computed tomography in patients with compensated chronic liver disease from hepatitis B viral infection. Eur Radiol. 2020. PMID: 32880698. doi:10.1007/s00330-020-07209-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。